Table 4 Health care behaviour: reported use of cancer screening tests
Tests carried out on subjects with an increased risk (n (%)) | |||||
|---|---|---|---|---|---|
Ever | In 6 months prior | At clinic | In 1 month since | In 12 months since | |
Increased breast cancer risk (n=103) | |||||
Breast exam | 90 (87%) | 47 (46%) | 53 (51%) | 4 (4%) | 25 (24%) |
Mammogram | 61 (59%) | 20 (19%) | 22 (21%) | 5 (5%) | 27 (26%) |
Breast U/S | 32 (31%) | 11 (11%) | N/K | 0 (0%) | 6 (6%) |
CA125 | 27 (26%) | 10 (10%) | N/K | 5 (5%) | 15 (15%) |
Ovarian other | 21 (20%) | 2 (2%) | N/K | 1 (1%) | 5 (5%) |
Increased bowel cancer risk (n=28) | |||||
CA125a | 1 (5%) | 0 (0%) | N/K | 0 (0%) | 0 (0%) |
Ovarian othera | 4 (19%) | 1 (4%) | N/K | 0 (0%) | 1 (5%) |
Colonoscopy | 15 (54%) | 10 (36%) | N/K | 1 (4%) | 11 (39%) |
